VIVIOPTAL WOMEN
Natural health product licensed in Canada
- Licence holder
- Bomuca International Corporation
- NPN or DIN-HM
- 80053992
- Status
- Inactive licence
- Licence date
- 17 September 2014
- Revision date
- Not provided
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Sélénium: up to 200 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 5 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 20 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B12 Source : Cyanocobalamine | 20 mcg | 20 µg |
| Riboflavine Source : Riboflavine | 1.5 mg | 1,500 µg |
| Zinc Source : Produit de chélation de zinc et de protéine végétale hydrolysée (PVH) | 8 mg | 8,000 µg |
| Potassium Source : Chlorure de potassium | 1.5 mg | 1,500 µg |
| Inositol Source : Inositol | 5 mg | Not calculated |
| Chrome Source : Polynicotinate chromique | 25 mcg | 25 µg |
| Glycyrrhiza glabra Source : Racine | 10 mg | Not calculated |
| Manganèse Source : Produit de chélation de manganèse et de PVH | 1 mg | 1,000 µg |
| Vitamine E Source : d-alpha-tocophérol Potency : 50 UI | 33.5 mg AT | Not calculated |
| Magnésium Source : Oxyde de magnésium | 40 mg | 40,000 µg |
| Molybdène Source : Produit de chélation de molybdène et de protéine végétale hydrolysée (PVH) | 25 mcg | 25 µg |
| Niacinamide Source : Niacinamide | 15 mg | Not calculated |
| Acide pantothénique Source : D-pantothénate de calcium | 9.2 mg | 9,200 µg |
| Sélénium Source : Sélénométhionine | 200 mcg | 200 µg |
| Lentinula edodes Source : Corps fructifère | 5 mg | Not calculated |
| Thiamine Source : Chlorhydrate de thiamine | 1 mg | 1,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 5 mg | 5,000 µg |
| Vitamine C Source : Ascorbate de sodium | 75 mg | 75,000 µg |
| Vitamine D Source : Cholécalciférol Potency : 800 UI | 20 mcg | 20 µg |
| Biotine Source : Biotine | 200 mcg | 200 µg |
Non-medicinal ingredients
Gélatine, Huile de soja, Lécithine, Dioxyde de titane, Cire d'abeille, FD&C Blue #1, Ethyl Vanillin, Rouge FD&C N° 40, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 1 Gélule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps to form red blood cells. Helps normal growth and development. Helps in tissue formation. Helps normal growth. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. An antioxidant for the maintenance of good health. Provides support for healthy glucose metabolism. Source of vitamin A to help maintain eyesight, skin, membranes and immune function. Source of vitamin A to help in the development and maintenance of night vision. Source of vitamin A to help in the development and maintenance of bones and teeth. Provides antioxidants for the maintenance of good health. Helps in connective tissue formation. Helps to maintain healthy skin. Helps to maintain immune function. Helps to maintain proper muscle function. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80053992
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.